oncology referral centers in England) is led by Prof. Heinrich Heimann, maintains a close collaboration with the Liverpool Ocular Oncology Research Group (LOORG) (www.loorg.eu.com) and is led by the internationally respected eye pathologist Prof. Sarah Coupland.
Recently sponsored by the The Eye Cancer Foundation, Dr Chandrani (Rani) Chattopadhyay from MD Anderson Cancer Center (left photograph) successfully completed a fellowship at LOORG. Similar to Prof. Coupland’s team, Rani has a particular interest in uveal melanoma, the most common cancer arising in the eye in adults. Unfortunately, close to half of uveal melanoma patients, develop 2 secondary (and often fatal) tumors in the liver, despite adequate treatment of the eye. Rani and LOORG worked together on cell lines, and cell culture models to understand and determine uveal melanoma drug sensitivites.
This year, LOORG is hosting another ECF Fellow. Dr. Iguaracyra (Cyra) raujo, a consultant pathologist from Bahia, Brazil (right photograph). Cyra has great expertise in lymphomas, tumors that arise from cancerous white blood cells. These tumors can occur inside the eye as well as in the surrounding tissues (eyelids, orbits and conjunctiva). Together, Prof. Coupland and Dr Araujo are
comparing and analyzing ocular lymphomas from Brazil and England for certain genetic changes, aiming to better understand how they arise. Around the world, The Eye Cancer Foundation’s support continues to enable collaborative research to better understand and cure eye cancer.